NCT07033832 Acceptance and Commitment Therapy-based Intervention for Parents of a Child With Medical Complexity
| NCT ID | NCT07033832 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Hong Kong Polytechnic University |
| Condition | Acceptance and Commitment Therapy |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-07-02 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-07-02 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A pilot randomized controlled trial of an Acceptance and Commitment Therapy-based intervention will be conducted to decrease psychological symptoms, while increase psychological flexibility for parents of a child with medical complexity during their difficulties.
Eligibility Criteria
Inclusion Criteria: * parent of a child with medical complexity aged 1-18 * able to communicate in Chinese and read Chinese * willing to participate in face-to-face activities Exclusion Criteria: * a reported mental health disorder * engaging in other psychosocial educational programs related to stress reduction * inability to communicate in Cantonese
Contact & Investigator
Winsome LAM, PhD
PRINCIPAL INVESTIGATOR
The Hong Kong Polytechnic University
Frequently Asked Questions
Who can join the NCT07033832 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acceptance and Commitment Therapy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07033832 currently recruiting?
Yes, NCT07033832 is actively recruiting participants. Contact the research team at winsome.lam@polyu.edu.hk for enrollment information.
Where is the NCT07033832 trial being conducted?
This trial is being conducted at Hong Kong, China, Kowloon, Hong Kong.
Who is sponsoring the NCT07033832 clinical trial?
NCT07033832 is sponsored by The Hong Kong Polytechnic University. The principal investigator is Winsome LAM, PhD at The Hong Kong Polytechnic University. The trial plans to enroll 30 participants.